Edward Melanson
Concepts (381)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Energy Metabolism | 58 | 2026 | 930 | 7.990 |
Why?
| | Exercise | 53 | 2026 | 2206 | 4.510 |
Why?
| | Weight Loss | 30 | 2026 | 857 | 4.360 |
Why?
| | Energy Intake | 35 | 2026 | 506 | 3.580 |
Why?
| | Calorimetry, Indirect | 21 | 2025 | 72 | 2.880 |
Why?
| | Obesity | 34 | 2026 | 3123 | 2.470 |
Why?
| | Fasting | 9 | 2025 | 280 | 2.020 |
Why?
| | Caloric Restriction | 8 | 2025 | 133 | 1.960 |
Why?
| | Thermogenesis | 6 | 2024 | 45 | 1.830 |
Why?
| | Overweight | 15 | 2026 | 613 | 1.720 |
Why?
| | Calorimetry | 11 | 2026 | 69 | 1.530 |
Why?
| | Weight Reduction Programs | 6 | 2025 | 140 | 1.410 |
Why?
| | Body Composition | 24 | 2026 | 686 | 1.400 |
Why?
| | Dietary Fats | 8 | 2026 | 307 | 1.370 |
Why?
| | Adipose Tissue, Brown | 3 | 2024 | 60 | 1.370 |
Why?
| | Sleep | 17 | 2026 | 896 | 1.280 |
Why?
| | Breakfast | 2 | 2020 | 20 | 1.260 |
Why?
| | Eating | 12 | 2022 | 386 | 1.220 |
Why?
| | Meals | 5 | 2020 | 130 | 1.190 |
Why?
| | Resistance Training | 7 | 2025 | 185 | 1.180 |
Why?
| | Diet | 11 | 2026 | 1271 | 1.170 |
Why?
| | Accelerometry | 7 | 2026 | 123 | 1.080 |
Why?
| | Oxygen Consumption | 13 | 2025 | 719 | 0.970 |
Why?
| | Basal Metabolism | 9 | 2026 | 58 | 0.920 |
Why?
| | Body Weight | 12 | 2026 | 964 | 0.870 |
Why?
| | Sleep Deprivation | 10 | 2026 | 207 | 0.860 |
Why?
| | Adult | 79 | 2026 | 40821 | 0.840 |
Why?
| | Walking | 10 | 2025 | 544 | 0.820 |
Why?
| | Gonadotropin-Releasing Hormone | 4 | 2024 | 215 | 0.800 |
Why?
| | Circadian Rhythm | 13 | 2024 | 514 | 0.800 |
Why?
| | Premenopause | 3 | 2020 | 129 | 0.790 |
Why?
| | Oxygen Isotopes | 5 | 2021 | 24 | 0.780 |
Why?
| | Monitoring, Physiologic | 6 | 2024 | 278 | 0.780 |
Why?
| | Estradiol | 2 | 2018 | 517 | 0.770 |
Why?
| | Female | 96 | 2026 | 79080 | 0.770 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2024 | 165 | 0.760 |
Why?
| | Humans | 131 | 2026 | 145625 | 0.750 |
Why?
| | Behavior Therapy | 3 | 2021 | 290 | 0.750 |
Why?
| | Body Mass Index | 21 | 2026 | 2446 | 0.750 |
Why?
| | Cancer Survivors | 3 | 2025 | 347 | 0.740 |
Why?
| | Appetite | 6 | 2025 | 80 | 0.740 |
Why?
| | Dietary Carbohydrates | 8 | 2019 | 145 | 0.720 |
Why?
| | Time Factors | 23 | 2026 | 7079 | 0.720 |
Why?
| | Lipid Metabolism | 5 | 2012 | 533 | 0.720 |
Why?
| | Exercise Therapy | 5 | 2025 | 486 | 0.710 |
Why?
| | Dietary Proteins | 7 | 2019 | 135 | 0.700 |
Why?
| | Water | 4 | 2024 | 451 | 0.700 |
Why?
| | Middle Aged | 51 | 2026 | 36359 | 0.670 |
Why?
| | Male | 92 | 2026 | 73014 | 0.670 |
Why?
| | Ovary | 3 | 2020 | 235 | 0.650 |
Why?
| | Weight Gain | 11 | 2026 | 561 | 0.630 |
Why?
| | Estrogens | 2 | 2024 | 364 | 0.620 |
Why?
| | Reference Standards | 1 | 2020 | 176 | 0.620 |
Why?
| | Exercise Test | 10 | 2024 | 634 | 0.590 |
Why?
| | Adipose Tissue, White | 1 | 2018 | 43 | 0.550 |
Why?
| | Pulmonary Gas Exchange | 2 | 2018 | 117 | 0.550 |
Why?
| | Arthroplasty, Replacement, Knee | 4 | 2025 | 383 | 0.540 |
Why?
| | Exercise Tolerance | 3 | 2025 | 288 | 0.540 |
Why?
| | Fats | 3 | 2009 | 13 | 0.520 |
Why?
| | Young Adult | 25 | 2025 | 14240 | 0.520 |
Why?
| | Physical Exertion | 5 | 2018 | 204 | 0.510 |
Why?
| | Isotope Labeling | 1 | 2017 | 81 | 0.500 |
Why?
| | Cross-Over Studies | 11 | 2026 | 612 | 0.500 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2019 | 197 | 0.480 |
Why?
| | Rest | 4 | 2018 | 126 | 0.460 |
Why?
| | Leuprolide | 1 | 2015 | 21 | 0.450 |
Why?
| | Breast Neoplasms | 3 | 2025 | 2411 | 0.440 |
Why?
| | Oxidation-Reduction | 11 | 2019 | 1075 | 0.440 |
Why?
| | Muscle, Skeletal | 6 | 2014 | 1795 | 0.430 |
Why?
| | Infant Nutritional Physiological Phenomena | 2 | 2026 | 159 | 0.410 |
Why?
| | Mass Spectrometry | 1 | 2017 | 728 | 0.410 |
Why?
| | Autonomic Nervous System Diseases | 2 | 2025 | 38 | 0.410 |
Why?
| | Hunger | 2 | 2021 | 56 | 0.410 |
Why?
| | Cold Temperature | 3 | 2024 | 207 | 0.410 |
Why?
| | Reproducibility of Results | 14 | 2025 | 3396 | 0.390 |
Why?
| | Monitoring, Ambulatory | 4 | 2017 | 88 | 0.360 |
Why?
| | Fatty Acids | 3 | 2012 | 460 | 0.360 |
Why?
| | Feeding Behavior | 6 | 2025 | 691 | 0.340 |
Why?
| | Parkinson Disease | 3 | 2025 | 614 | 0.340 |
Why?
| | Appetite Regulation | 3 | 2021 | 31 | 0.340 |
Why?
| | Temperature | 1 | 2014 | 633 | 0.340 |
Why?
| | Thinness | 1 | 2012 | 99 | 0.340 |
Why?
| | Deglutition | 5 | 2014 | 73 | 0.330 |
Why?
| | Heart Rate | 7 | 2025 | 844 | 0.320 |
Why?
| | Wearable Electronic Devices | 2 | 2024 | 75 | 0.310 |
Why?
| | Activities of Daily Living | 4 | 2018 | 438 | 0.310 |
Why?
| | Perception | 1 | 2013 | 372 | 0.310 |
Why?
| | Adaptation, Physiological | 4 | 2026 | 567 | 0.300 |
Why?
| | Carbon Dioxide | 2 | 2010 | 228 | 0.300 |
Why?
| | Melatonin | 5 | 2023 | 164 | 0.300 |
Why?
| | Work Schedule Tolerance | 3 | 2020 | 51 | 0.290 |
Why?
| | Food | 3 | 2024 | 149 | 0.290 |
Why?
| | Body Weight Maintenance | 2 | 2019 | 18 | 0.290 |
Why?
| | Lipid Peroxidation | 1 | 2009 | 168 | 0.280 |
Why?
| | Ghrelin | 6 | 2025 | 42 | 0.270 |
Why?
| | Posture | 5 | 2016 | 180 | 0.270 |
Why?
| | Adaptation, Psychological | 1 | 2013 | 718 | 0.260 |
Why?
| | Weight Lifting | 2 | 2009 | 31 | 0.260 |
Why?
| | Spectrum Analysis | 3 | 2019 | 85 | 0.250 |
Why?
| | Menopause | 2 | 2022 | 327 | 0.250 |
Why?
| | Anorexia Nervosa | 2 | 2005 | 82 | 0.250 |
Why?
| | Dietary Sugars | 1 | 2026 | 21 | 0.240 |
Why?
| | Gastrointestinal Microbiome | 3 | 2026 | 767 | 0.240 |
Why?
| | Fast Foods | 1 | 2026 | 24 | 0.240 |
Why?
| | Cardiovascular Diseases | 3 | 2024 | 2218 | 0.240 |
Why?
| | Sodium, Dietary | 1 | 2026 | 43 | 0.240 |
Why?
| | Regression Analysis | 4 | 2025 | 994 | 0.240 |
Why?
| | Wakefulness | 5 | 2020 | 169 | 0.240 |
Why?
| | Adolescent | 16 | 2026 | 22451 | 0.240 |
Why?
| | Carbohydrate Metabolism | 3 | 2006 | 59 | 0.240 |
Why?
| | Weaning | 1 | 2026 | 50 | 0.230 |
Why?
| | Bicycling | 2 | 2025 | 117 | 0.230 |
Why?
| | Infant Food | 1 | 2026 | 69 | 0.230 |
Why?
| | Peptide YY | 5 | 2025 | 28 | 0.230 |
Why?
| | Diet, Vegetarian | 1 | 2025 | 11 | 0.230 |
Why?
| | Calcium, Dietary | 1 | 2005 | 52 | 0.230 |
Why?
| | Deuterium | 4 | 2021 | 101 | 0.230 |
Why?
| | Metabolic Syndrome | 1 | 2009 | 364 | 0.230 |
Why?
| | Shoes | 5 | 2017 | 19 | 0.230 |
Why?
| | Delay Discounting | 1 | 2025 | 29 | 0.220 |
Why?
| | Mastication | 4 | 2014 | 12 | 0.210 |
Why?
| | Physical Endurance | 3 | 2009 | 278 | 0.210 |
Why?
| | Sports Equipment | 1 | 2004 | 9 | 0.210 |
Why?
| | Nutritive Value | 2 | 2026 | 41 | 0.210 |
Why?
| | Eyeglasses | 1 | 2024 | 26 | 0.210 |
Why?
| | Signal Processing, Computer-Assisted | 3 | 2017 | 151 | 0.200 |
Why?
| | Double-Blind Method | 3 | 2019 | 2064 | 0.200 |
Why?
| | Guidelines as Topic | 1 | 2025 | 267 | 0.200 |
Why?
| | Osteoarthritis, Knee | 2 | 2025 | 284 | 0.200 |
Why?
| | Consensus | 1 | 2025 | 465 | 0.200 |
Why?
| | Cardiorespiratory Fitness | 2 | 2024 | 73 | 0.190 |
Why?
| | Physical Fitness | 2 | 2013 | 207 | 0.190 |
Why?
| | HIV Integrase | 1 | 2024 | 74 | 0.190 |
Why?
| | Motor Activity | 3 | 2019 | 701 | 0.190 |
Why?
| | HIV Integrase Inhibitors | 1 | 2024 | 80 | 0.190 |
Why?
| | Health Behavior | 2 | 2025 | 801 | 0.190 |
Why?
| | Biomarkers | 5 | 2024 | 4329 | 0.190 |
Why?
| | Puberty | 2 | 2014 | 141 | 0.180 |
Why?
| | Bariatric Surgery | 1 | 2026 | 248 | 0.180 |
Why?
| | Research Design | 2 | 2025 | 1139 | 0.180 |
Why?
| | Insulin Resistance | 4 | 2019 | 1247 | 0.180 |
Why?
| | Positron-Emission Tomography | 1 | 2024 | 342 | 0.180 |
Why?
| | Obesity, Morbid | 1 | 2026 | 284 | 0.170 |
Why?
| | Circadian Clocks | 2 | 2019 | 59 | 0.170 |
Why?
| | Bone Density | 2 | 2015 | 492 | 0.170 |
Why?
| | Diet, Fat-Restricted | 3 | 2011 | 79 | 0.170 |
Why?
| | France | 1 | 2021 | 40 | 0.170 |
Why?
| | Child Development | 1 | 2026 | 481 | 0.170 |
Why?
| | Analysis of Variance | 6 | 2021 | 1293 | 0.160 |
Why?
| | Bone Remodeling | 1 | 2021 | 71 | 0.160 |
Why?
| | Fruit | 1 | 2021 | 144 | 0.160 |
Why?
| | Aging | 2 | 2012 | 1983 | 0.160 |
Why?
| | Diabetes Mellitus | 1 | 2009 | 1101 | 0.160 |
Why?
| | Diet Records | 3 | 2026 | 87 | 0.160 |
Why?
| | Nitrogen | 2 | 2012 | 125 | 0.160 |
Why?
| | Vegetables | 1 | 2021 | 159 | 0.160 |
Why?
| | Leptin | 5 | 2026 | 247 | 0.160 |
Why?
| | Glucose | 2 | 2024 | 1051 | 0.160 |
Why?
| | Starch | 1 | 2019 | 22 | 0.150 |
Why?
| | Contraceptive Agents | 1 | 2020 | 65 | 0.150 |
Why?
| | Amputees | 1 | 2021 | 101 | 0.150 |
Why?
| | Aged | 15 | 2025 | 26251 | 0.150 |
Why?
| | Sweating | 1 | 2019 | 43 | 0.150 |
Why?
| | Randomized Controlled Trials as Topic | 5 | 2026 | 1754 | 0.150 |
Why?
| | Cross-Sectional Studies | 6 | 2023 | 5875 | 0.140 |
Why?
| | Metabolomics | 2 | 2026 | 737 | 0.140 |
Why?
| | Inpatients | 1 | 2023 | 538 | 0.140 |
Why?
| | Parathyroid Hormone | 1 | 2019 | 118 | 0.140 |
Why?
| | Adipocytes | 2 | 2018 | 223 | 0.140 |
Why?
| | Hospitals | 1 | 2023 | 730 | 0.140 |
Why?
| | Body Temperature | 2 | 2010 | 227 | 0.140 |
Why?
| | Proof of Concept Study | 1 | 2018 | 89 | 0.140 |
Why?
| | Telerehabilitation | 1 | 2019 | 49 | 0.130 |
Why?
| | Kidney | 1 | 2026 | 1491 | 0.130 |
Why?
| | Postprandial Period | 3 | 2020 | 114 | 0.130 |
Why?
| | Guideline Adherence | 1 | 2022 | 585 | 0.130 |
Why?
| | Brain Mapping | 3 | 2016 | 540 | 0.130 |
Why?
| | High-Intensity Interval Training | 1 | 2018 | 45 | 0.130 |
Why?
| | Liver | 1 | 2026 | 1859 | 0.130 |
Why?
| | Artificial Limbs | 1 | 2021 | 215 | 0.130 |
Why?
| | Postmenopause | 1 | 2019 | 394 | 0.120 |
Why?
| | Diet, Reducing | 3 | 2025 | 90 | 0.120 |
Why?
| | Pilot Projects | 5 | 2022 | 1878 | 0.120 |
Why?
| | Time-to-Treatment | 1 | 2019 | 257 | 0.120 |
Why?
| | Computer Storage Devices | 1 | 2016 | 2 | 0.120 |
Why?
| | Tachycardia, Ventricular | 1 | 2018 | 179 | 0.120 |
Why?
| | Algorithms | 4 | 2015 | 1843 | 0.120 |
Why?
| | Self Report | 1 | 2021 | 869 | 0.120 |
Why?
| | Gait | 2 | 2017 | 316 | 0.120 |
Why?
| | Brain | 4 | 2025 | 2981 | 0.120 |
Why?
| | Odds Ratio | 1 | 2019 | 1070 | 0.120 |
Why?
| | Combined Modality Therapy | 1 | 2019 | 1269 | 0.120 |
Why?
| | Microbiota | 1 | 2023 | 724 | 0.120 |
Why?
| | Homeostasis | 3 | 2019 | 646 | 0.110 |
Why?
| | Life Style | 2 | 2021 | 495 | 0.110 |
Why?
| | Estrogens, Conjugated (USP) | 1 | 2015 | 52 | 0.110 |
Why?
| | Needs Assessment | 1 | 2018 | 403 | 0.110 |
Why?
| | Skin | 1 | 2019 | 701 | 0.110 |
Why?
| | Defibrillators, Implantable | 1 | 2018 | 393 | 0.110 |
Why?
| | Triglycerides | 2 | 2019 | 527 | 0.110 |
Why?
| | Sleep Stages | 1 | 2014 | 76 | 0.100 |
Why?
| | Blood Glucose | 4 | 2020 | 2357 | 0.100 |
Why?
| | Veterans | 5 | 2025 | 1647 | 0.100 |
Why?
| | Animals | 8 | 2025 | 38030 | 0.100 |
Why?
| | Health Status | 1 | 2019 | 822 | 0.100 |
Why?
| | Waist Circumference | 2 | 2026 | 142 | 0.100 |
Why?
| | Calcium | 1 | 2019 | 1181 | 0.100 |
Why?
| | Muscle Fatigue | 1 | 2014 | 98 | 0.100 |
Why?
| | Proteome | 1 | 2018 | 520 | 0.100 |
Why?
| | Nervous System Physiological Phenomena | 1 | 2013 | 22 | 0.090 |
Why?
| | Cell Phone | 1 | 2014 | 83 | 0.090 |
Why?
| | Task Performance and Analysis | 1 | 2014 | 203 | 0.090 |
Why?
| | Sound Spectrography | 2 | 2009 | 15 | 0.090 |
Why?
| | Blood Pressure | 1 | 2019 | 1761 | 0.090 |
Why?
| | Adiposity | 4 | 2026 | 531 | 0.090 |
Why?
| | Surveys and Questionnaires | 3 | 2023 | 6050 | 0.090 |
Why?
| | Hydrogen | 1 | 2012 | 73 | 0.090 |
Why?
| | Urinalysis | 1 | 2012 | 82 | 0.090 |
Why?
| | Insulin | 5 | 2020 | 2524 | 0.090 |
Why?
| | Area Under Curve | 1 | 2013 | 333 | 0.090 |
Why?
| | Lasers | 1 | 2012 | 127 | 0.090 |
Why?
| | Smoking | 1 | 2019 | 1478 | 0.090 |
Why?
| | Adipose Tissue | 3 | 2011 | 641 | 0.080 |
Why?
| | Hot Temperature | 2 | 2018 | 396 | 0.080 |
Why?
| | Case-Control Studies | 4 | 2021 | 3633 | 0.080 |
Why?
| | Sex Factors | 2 | 2014 | 2101 | 0.080 |
Why?
| | Aged, 80 and over | 5 | 2021 | 8351 | 0.080 |
Why?
| | Magnetic Resonance Imaging | 4 | 2025 | 3917 | 0.080 |
Why?
| | Nerve Net | 1 | 2013 | 284 | 0.080 |
Why?
| | Physical Phenomena | 1 | 2010 | 13 | 0.080 |
Why?
| | Heart Failure | 1 | 2024 | 2323 | 0.080 |
Why?
| | Chronic Disease | 3 | 2024 | 1824 | 0.080 |
Why?
| | Muscle Proteins | 1 | 2012 | 242 | 0.080 |
Why?
| | Prospective Studies | 5 | 2021 | 8087 | 0.080 |
Why?
| | Collagen Type I | 2 | 2021 | 144 | 0.070 |
Why?
| | Diet Surveys | 1 | 2009 | 89 | 0.070 |
Why?
| | Glycerol | 1 | 2009 | 90 | 0.070 |
Why?
| | Somatotypes | 1 | 2009 | 4 | 0.070 |
Why?
| | Spirometry | 1 | 2010 | 234 | 0.070 |
Why?
| | Pattern Recognition, Automated | 1 | 2009 | 74 | 0.070 |
Why?
| | Models, Biological | 3 | 2018 | 1758 | 0.070 |
Why?
| | Cues | 1 | 2011 | 326 | 0.070 |
Why?
| | Thermography | 1 | 2009 | 9 | 0.070 |
Why?
| | Validation Studies as Topic | 1 | 2009 | 23 | 0.070 |
Why?
| | Nutritional Requirements | 2 | 2024 | 78 | 0.070 |
Why?
| | Auscultation | 1 | 2008 | 4 | 0.070 |
Why?
| | Kinetics | 1 | 2012 | 1553 | 0.070 |
Why?
| | Age Factors | 2 | 2007 | 3321 | 0.070 |
Why?
| | Healthy Volunteers | 2 | 2019 | 217 | 0.070 |
Why?
| | Cerebral Cortex | 1 | 2011 | 481 | 0.070 |
Why?
| | HIV Infections | 1 | 2024 | 3210 | 0.070 |
Why?
| | Respiratory Function Tests | 1 | 2010 | 543 | 0.070 |
Why?
| | Dietary Supplements | 1 | 2012 | 586 | 0.070 |
Why?
| | Body Fat Distribution | 1 | 2007 | 46 | 0.060 |
Why?
| | Colorado | 3 | 2021 | 4588 | 0.060 |
Why?
| | Phosphorylation | 1 | 2012 | 1717 | 0.060 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2007 | 154 | 0.060 |
Why?
| | Rats, Wistar | 4 | 2011 | 449 | 0.060 |
Why?
| | Reference Values | 2 | 2012 | 787 | 0.060 |
Why?
| | Norepinephrine | 1 | 2007 | 201 | 0.060 |
Why?
| | Sensitivity and Specificity | 3 | 2012 | 1992 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2021 | 2623 | 0.060 |
Why?
| | Dairy Products | 1 | 2005 | 30 | 0.060 |
Why?
| | Gene Expression Regulation | 2 | 2012 | 2591 | 0.060 |
Why?
| | Micronutrients | 1 | 2026 | 102 | 0.060 |
Why?
| | Patient Selection | 1 | 2009 | 720 | 0.060 |
Why?
| | Transcription, Genetic | 1 | 2012 | 1429 | 0.060 |
Why?
| | Actigraphy | 1 | 2026 | 148 | 0.050 |
Why?
| | Telemedicine | 2 | 2025 | 956 | 0.050 |
Why?
| | Organ Size | 1 | 2026 | 463 | 0.050 |
Why?
| | Recovery of Function | 2 | 2025 | 721 | 0.050 |
Why?
| | Photoperiod | 2 | 2019 | 55 | 0.050 |
Why?
| | Gyrus Cinguli | 1 | 2025 | 97 | 0.050 |
Why?
| | Longitudinal Studies | 2 | 2026 | 3005 | 0.050 |
Why?
| | Polysomnography | 2 | 2020 | 239 | 0.050 |
Why?
| | Parasympathetic Nervous System | 1 | 2004 | 26 | 0.050 |
Why?
| | Shift Work Schedule | 1 | 2024 | 10 | 0.050 |
Why?
| | Equipment Design | 2 | 2017 | 519 | 0.050 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2004 | 64 | 0.050 |
Why?
| | Treatment Outcome | 4 | 2025 | 11744 | 0.050 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2025 | 155 | 0.050 |
Why?
| | Canada | 1 | 2025 | 430 | 0.050 |
Why?
| | Clinical Trials as Topic | 1 | 2009 | 1062 | 0.050 |
Why?
| | Long QT Syndrome | 1 | 2005 | 68 | 0.050 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2025 | 429 | 0.050 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2025 | 196 | 0.050 |
Why?
| | Statistics as Topic | 1 | 2004 | 277 | 0.050 |
Why?
| | Thrombophilia | 1 | 2024 | 89 | 0.050 |
Why?
| | Impulsive Behavior | 1 | 2025 | 146 | 0.050 |
Why?
| | Adiponectin | 1 | 2025 | 243 | 0.050 |
Why?
| | Linear Models | 2 | 2018 | 847 | 0.050 |
Why?
| | Walk Test | 1 | 2023 | 82 | 0.050 |
Why?
| | Reaction Time | 1 | 2025 | 434 | 0.050 |
Why?
| | Integrases | 1 | 2024 | 117 | 0.050 |
Why?
| | Anaerobic Threshold | 1 | 2002 | 29 | 0.050 |
Why?
| | Sampling Studies | 1 | 2002 | 97 | 0.050 |
Why?
| | Sensation | 1 | 2022 | 56 | 0.050 |
Why?
| | Blood Coagulation | 1 | 2024 | 267 | 0.050 |
Why?
| | Hormones | 2 | 2016 | 134 | 0.050 |
Why?
| | Triazoles | 1 | 2024 | 190 | 0.040 |
Why?
| | Women's Health | 1 | 2004 | 317 | 0.040 |
Why?
| | Electromyography | 2 | 2014 | 417 | 0.040 |
Why?
| | Infant | 2 | 2026 | 10093 | 0.040 |
Why?
| | Pyridones | 1 | 2024 | 210 | 0.040 |
Why?
| | Prefrontal Cortex | 1 | 2025 | 338 | 0.040 |
Why?
| | Satiation | 1 | 2021 | 26 | 0.040 |
Why?
| | Recurrence | 2 | 2019 | 1125 | 0.040 |
Why?
| | Self-Management | 1 | 2024 | 207 | 0.040 |
Why?
| | Osteocalcin | 1 | 2021 | 37 | 0.040 |
Why?
| | Craving | 1 | 2021 | 41 | 0.040 |
Why?
| | Perimenopause | 1 | 2022 | 69 | 0.040 |
Why?
| | Muscle Strength | 1 | 2024 | 332 | 0.040 |
Why?
| | Proteins | 2 | 2006 | 1021 | 0.040 |
Why?
| | Patient Reported Outcome Measures | 1 | 2025 | 502 | 0.040 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2021 | 150 | 0.040 |
Why?
| | Absorptiometry, Photon | 2 | 2016 | 276 | 0.040 |
Why?
| | United States | 3 | 2026 | 16041 | 0.040 |
Why?
| | Uncoupling Protein 1 | 1 | 2019 | 17 | 0.040 |
Why?
| | Rats | 4 | 2011 | 5574 | 0.040 |
Why?
| | Disability Evaluation | 1 | 2021 | 297 | 0.040 |
Why?
| | Iodide Peroxidase | 1 | 2019 | 34 | 0.040 |
Why?
| | Bone Resorption | 1 | 2019 | 80 | 0.040 |
Why?
| | Decision Trees | 1 | 2018 | 75 | 0.030 |
Why?
| | Acidosis | 1 | 2019 | 105 | 0.030 |
Why?
| | Mathematical Concepts | 1 | 2018 | 35 | 0.030 |
Why?
| | Feces | 1 | 2021 | 494 | 0.030 |
Why?
| | Humidity | 1 | 2018 | 50 | 0.030 |
Why?
| | Methanol | 1 | 2018 | 43 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2019 | 312 | 0.030 |
Why?
| | Patient Discharge | 1 | 2025 | 991 | 0.030 |
Why?
| | Solvents | 1 | 2018 | 112 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2022 | 1125 | 0.030 |
Why?
| | Europe | 1 | 2018 | 420 | 0.030 |
Why?
| | Wrist | 1 | 2017 | 60 | 0.030 |
Why?
| | Health Promotion | 1 | 2023 | 786 | 0.030 |
Why?
| | Lower Extremity | 1 | 2021 | 449 | 0.030 |
Why?
| | Materials Testing | 1 | 2018 | 345 | 0.030 |
Why?
| | Plasma | 1 | 2018 | 222 | 0.030 |
Why?
| | Methods | 1 | 1996 | 68 | 0.030 |
Why?
| | Maximal Voluntary Ventilation | 1 | 2016 | 9 | 0.030 |
Why?
| | Equipment and Supplies | 1 | 1996 | 36 | 0.030 |
Why?
| | Sex Characteristics | 1 | 2002 | 798 | 0.030 |
Why?
| | Self Disclosure | 1 | 1996 | 62 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2021 | 2097 | 0.030 |
Why?
| | Carbon Isotopes | 1 | 1996 | 143 | 0.030 |
Why?
| | Proteomics | 1 | 2022 | 1202 | 0.030 |
Why?
| | Smartphone | 1 | 2016 | 103 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2016 | 360 | 0.030 |
Why?
| | Nontherapeutic Human Experimentation | 1 | 2014 | 3 | 0.030 |
Why?
| | Support Vector Machine | 1 | 2014 | 33 | 0.030 |
Why?
| | Disease Models, Animal | 3 | 2011 | 4565 | 0.020 |
Why?
| | Child | 3 | 2024 | 22638 | 0.020 |
Why?
| | Peptides | 1 | 2019 | 991 | 0.020 |
Why?
| | Logistic Models | 1 | 2018 | 2112 | 0.020 |
Why?
| | Risk Factors | 2 | 2020 | 10840 | 0.020 |
Why?
| | Machine Learning | 1 | 2018 | 590 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 1034 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2023 | 17291 | 0.020 |
Why?
| | Anabolic Agents | 1 | 2012 | 13 | 0.020 |
Why?
| | Interviews as Topic | 1 | 1996 | 926 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1467 | 0.020 |
Why?
| | Sleep Wake Disorders | 1 | 2015 | 314 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2016 | 774 | 0.020 |
Why?
| | Muscle Contraction | 1 | 2014 | 427 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2015 | 2018 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2019 | 2783 | 0.020 |
Why?
| | Transcription Factors | 1 | 2019 | 1728 | 0.020 |
Why?
| | Photic Stimulation | 1 | 2011 | 265 | 0.020 |
Why?
| | Biomechanical Phenomena | 1 | 2014 | 868 | 0.020 |
Why?
| | Oxygen | 1 | 2016 | 996 | 0.020 |
Why?
| | Models, Theoretical | 1 | 2014 | 558 | 0.020 |
Why?
| | Geriatric Assessment | 1 | 2012 | 238 | 0.020 |
Why?
| | Fourier Analysis | 1 | 2009 | 41 | 0.020 |
Why?
| | Hydrostatic Pressure | 1 | 2009 | 30 | 0.020 |
Why?
| | Electric Impedance | 1 | 2009 | 108 | 0.020 |
Why?
| | Cognition | 1 | 2016 | 1286 | 0.020 |
Why?
| | Body Height | 1 | 2009 | 202 | 0.020 |
Why?
| | Arrhythmias, Cardiac | 1 | 2005 | 358 | 0.010 |
Why?
| | Mental Recall | 1 | 2003 | 224 | 0.010 |
Why?
| | Mice | 1 | 2019 | 18266 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2005 | 2910 | 0.010 |
Why?
|
|
Melanson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|